Weekly Digest – December 2024 Weekly Digest – December 2024 10 Dec 2024: NextCure announces acceptance of IND application for LNCB74 NextCure announced that the FDA accepted its Investigational New Drug (IND) application for LNCB74, a B7-H4-targeting antibody-drug conjugate (ADC) […]
Weekly Digest – December 2024 Weekly Digest – December 2024 09 Dec 2024: Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer Datopotamab deruxtecan (Dato-DXd) has received Breakthrough Therapy Designation […]
Weekly Digest – December 2024 Weekly Digest – December 2024 09 Dec 2024: Blenrep (belantamab mafodotin) combination accepted for priority review in China in relapsed/refractory multiple myeloma The National Medical Products Administration (NMPA) of China has accepted a new drug […]
